Belite Bio Payables and Accrued Expenses (Quarterly) Analysis

Belite Bio, Inc. (BLTE)

164.58 +4.72 (+2.96%) USD | NASDAQ | Jan 23, 16:00

164.50 -0.08 (-0.05%) Pre-Market: 20:00

View Payables and Accrued Expenses (Quarterly) for BLTE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial